CellMed
PrivateLast Round
Grant
Aug 25, 2026
Momentum
Top 1%
of companies Caplight tracks
Company Overview
CellMed is a South Korean pharmaceutical and biotechnology company that develops anticancer drugs and functional nutraceutical products based on natural phytochemicals.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, D2C Brands, Medical AI, Fashion & Beauty
Business Model
B2B2C
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CellMed Comparables
Compare CellMed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Yuhan Corporation | 69% | |
| Algocare | 63% | |
| Kick the Hurdle | 63% | |
CellMed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 25, 2026 |
CellMed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Government of South Korea | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 25, 2026
$1.31M grant from the Government of South Korea
CellMed Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CellMed's valuation, stock price, and market status.